Portfoliotracker

Avacta Group Plc

AVCT.L · LSE · Healthcare Biotechnology 0/100 E

56,42 GBP
▼ −0,68 (−1,20 %)
Trading delayed by 15 min
Price as of 17. 11. 12:25, fetched 17. 11. 12:50
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score0 / 100 Market cap22,8 mld. GBP P/E– Forward P/E-22,3 P/S202 083,5 P/B6 058,8 EV/EBITDA– Dividend yield– FCF yield-0,12 % EPS-0,09 GBP Net margin0,0 % Return on equity-1 965,1 % Beta-0,15 Debt / equity5,27
52-week range 48,00 to 92,00
3-month average volume1,9 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. The company's lead product candidate is AVA6000, a peptide drug conjugate form of doxorubicin, which is an approved cancer drug with known severe toxicities. It also develops AVA6103, a peptide drug conjugate technology designed to deliver exatecan, a potent topoisomerase I inhibitor directly to tumors while limiting the exposure of the released exatecan in normal tissues; and AVA7100 that drives localization to fibroblast activation protein expressing tumors. The company was incorporated in 2003 and is headquartered in London, the United Kingdom.

Website
avacta.com
Employees
81
Country
United Kingdom
Data since
8. 9. 2003

Explore further

Similar companies GGP.LEUA.L

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account